[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$camx Graphic $camx

Camurus reports strong quarterly results, driving positive investor sentiment. The company's collaboration with Eli Lilly and its innovative technology are key drivers.

About $camx

CAMX refers to Camurus, a biotechnology company.

Insights #

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Month: XXXXXX -XX%
1-Year High: XXXXX on 2025-06-03
1-Year Low: X on 2025-05-10

Social Network X
Engagements XXX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +167%
1 Month: XX +10%
1-Year High: X on 2025-06-05
1-Year Low: X on 2025-04-27

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $camx in the last XX hours which is no change from in the previous XX hours Daily Average: X
1 Week: X +200%
1 Month: X -XX%
1-Year High: X on 2025-06-04
1-Year Low: X on 2025-04-27

Top assets mentioned In the posts about $camx in the last XX hours

Eli Lilly and Company (LLY) Eli Lilly and Company (LLY)

Top topics mentioned In the posts about $camx in the last XX hours

$camxst, tax bracket, stocks technology, $lly, eli lilly, $4377t, $hrow, $5134t, $itm, $hbr, coins energy, $cadlr, eps, crmd, $crmd, $215at, $277at, $4493t

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$CAMX #Camurus new ATH - dip after Q2 results was a clear buying opportunity. Great growth story and broad pipeline. $LLY deal confirmed the potential of the FluidCrystal platform technology"
@doepke_michel on X 2025-07-21 07:47:07 UTC 4872 followers, 2099 engagements

"$CAMX.ST $CAMX Strong quarterly results from Camurus (part of my biotech basket): ➡ Revenue: SEK 675.5m +51.8% YoY (vs. SEK 653m est.) ➡ Operating profit: SEK 292.05m (43.2% margin) +253.5% YoY ➡ EPS: SEK XXXX +226.4% YoY (vs. SEK XXXX est.) Unchallenged market leader in opioid addiction treatment strong pipeline resubmission for CAM2029 (acromegaly treatment) in the U.S. expected in Q3/25 a recently announced long-term collaboration with Eli Lilly ($LLY) on its proprietary FluidCrystal technology incredible operating leverage lots to like here. In my view one of the best high-growth stocks"
@stock_logging on X 2025-07-17 09:00:25 UTC XXX followers, 1046 engagements